Clinical and Translational Radiation Oncology

Article	Citations
Stabilised Hyaluronic Acid (sHA) gel as a novel marker for breast cancer tumour bed cavity: Surgical feasibility	44
Oxygen-enhanced MRI and radiotherapy in patients with oropharyngeal squamous cell carcinoma	29
Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States – Understanding the transition to adaptive, ultra-hypofractionated treatments	26
Machine learning for dose-volume histogram based clinical decision-making support system in radiation therapy plans for brain tumors	22
Influence of intestinal microbial metabolites on the abscopal effect after radiation therapy combined with immune checkpoint inhibitors	21
Uterus motion analysis for radiotherapy planning optimization. The innovative contribution of on-board hybrid MR imaging	21
Measuring patient reported outcomes in brachytherapy: Why we should do it and more importantly how	16
Risk factor of pneumonitis on dose-volume relationship for chemoradiotherapy with durvalumab: Multi-institutional research in Japan	15
Bladder-preserving radiation therapy for patients with locally advanced and node-positive bladder cancer	13
Long-term outcomes of more than a decade treating patients with stereotactic body radiation therapy for hepatocellular carcinoma	13
Feasibility of tumour-focused adaptive radiotherapy for bladder cancer on the MR-linac	13
Avoiding prostate bed radiation for the PSMA-PET detected nodal recurrence patient post prostatectomy	13
Blood-brain barrier permeability following conventional photon radiotherapy – A systematic review and meta-analysis of clinical and preclinical studies	12
Effectiveness, toxicity and impact on quality of life of high-dose-rate brachytherapy delivered in two fractions as monotherapy in patients with prostate cancer	11
Dosimetric feasibility analysis and presentation of an isotoxic dose-escalated radiation therapy concept for glioblastoma used in the PRIDE trial (NOA-28; ARO-2022-12)	11
Longitudinal trajectory of quality of life for patients with melanoma brain metastases: A secondary analysis from a whole brain radiotherapy randomized clinical trial	11
Systemic therapy escalation after stereotactic body radiation therapy for oligometastatic hormone-sensitive prostate cancer	11
Toxicity profile and Patient-Reported outcomes following salvage Stereotactic Ablative Radiation Therapy to the prostate Bed: The POPART multicentric prospective study	11
Radiation response assessment of organoids derived from patients with pancreatic cancer	10
Developing and validating a simple urethra surrogate model to facilitate dosimetric analysis to predict genitourinary toxicity	9
Association between radiotherapy protocol variations and outcome in the CONVERT trial	9
A fully automated machine-learning-based workflow for radiation treatment planning in prostate cancer	9
Integrative prediction model for radiation pneumonitis incorporating genetic and clinical-pathological factors using machine learning	9
Predicting radiation-induced hypothyroidism in nasopharyngeal carcinoma patients using a deep learning model	9
Comparing supervised and semi-supervised machine learning approaches in NTCP modeling to predict complications in head and neck cancer patients	8

Comparison of 18F-FET-PET- and MRI-based target definition for re-irradiation treatment of recurrent diffuse glioma	8
Patient reported outcomes for quality of life (QOL) by Expanded Prostate Cancer Index (EPIC) on average 15 years post treatment	8
Comparison of simultaneous integrated tumor bed boost and sequential boost during hypofractionated whole-breast irradiation after breast-conserving surgery	8
Contemporary use and outcomes of radiation and chemotherapy for unresectable pancreatic cancer	8
A retrospective review of the long-term outcomes of online adaptive radiation therapy and conventional radiation therapy for muscle invasive bladder cancer	8
Investigation of the physiological response of radiation-induced cystitis patients using hyperbaric oxygen	7
Adaptive FDG-PET/CT guided dose escalation in head and neck squamous cell carcinoma: Late toxicity and oncologic outcomes (The ADMIRE study)	7
A single-institution phase I feasibility study of dose-escalated IMRT for non-operative locally advanced esophageal carcinoma	7
Comparative effectiveness of new treatment modalities for localized prostate cancer through patient-reported outcome measures	7
The ROCOCO performance scoring system translates dosimetric differences into clinically relevant endpoints: Comparing IMPT to VMAT in an example pilocytic astrocytoma dataset	7
Outcomes and predictors of response to fractionated radiotherapy as primary treatment for intracranial meningiomas	7
Early circulating tumor DNA dynamics at the commencement of curative-intent radiotherapy or chemoradiotherapy for NSCLC	6
MRI-guided radiotherapy in twenty fractions for localised prostate cancer; results from the MOMENTUM study	6
Setting the stage: The opening act of preoperative SRS for brain metastases	6
Stereotactic body radiotherapy for oligoprogressive lesions in metastatic castration‐resistant prostate cancer patients – A closer inspection will improve your vision	6
Morphological changes after cranial fractionated photon radiotherapy: Localized loss of white matter and grey matter volume with increasing dose	6
Artificial intelligence to predict outcomes of head and neck radiotherapy	6
Stereotactic ablative radiotherapy for treating primary head and neck cancer and locoregional recurrence: A comprehensive review of the literature	6
In regard to Kim et al	6
Cetuximab, gemcitabine and radiotherapy in locally advanced pancreatic cancer: Long-term results of the randomized controlled phase II PARC trial	6
The prognostic utility of IGF-1 in hepatocellular carcinoma treated with stereotactic body radiotherapy	6
Acute toxicity patterns and their management after moderate and ultra- hypofractionated radiotherapy for prostate cancer: A prospective cohort study	6
Metastases-directed radiotherapy in castration resistant oligo metastatic prostate cancer: A multicentric retrospective study from the French group COLib	6
The timing and design of stereotactic radiotherapy approaches as a part of neoadjuvant therapy in pancreatic cancer: Is it time for change?	6
Corrigendum to “Bridging the care gap: patients’ needs and experiences regarding shared decision-making in radiotherapy” [Clin. Translat. Radiat. Oncol. (2025) 100897]	6
Feasibility of low-dose radiotherapy for patients with stage I/II extranodal NK-/T-cell lymphoma, nasal type achieving complete response after l-asparaginase-containing chemotherapy	6
Immunohistochemical analyses of paraffin-embedded sections after primary surgery or trimodality treatment in esophageal carcinoma	5
The potential role of MR-guided adaptive radiotherapy in pediatric oncology: Results from a SIOPE-COG survey	5
Quantifying radiation-induced breast fibrosis by shear-wave elastography in patients with breast cancer: A 12-months-follow-up data of a prospective study	5
The first real-world study on the role of carbon ion radiotherapy for oligo-metastatic, persistent, or recurrent (MPR) ovarian/fallopian tube cancer	5
Does a peer review group consensus process for MR-Linac patients affect clinical care? Evaluation of impact and feasibility	5
Acute toxicities in proton therapy for head and neck cancer – A matched analysis of the DAHANCA 35 feasibility study	5
Refractory ventricular tachycardia treated by a second session of stereotactic arrhythmia radioablation	5
Complications leading to hospitalisation 12 months after brachytherapy or high-intensity focused ultrasound for localized prostate cancer: French national from the PMSI-MCO data, 2019 and 2020	5
Clinical outcomes of esophageal squamous cell carcinoma in patients with cirrhosis	5
Randomized clinical trial of tissue equivalent bolus prescription in postmastectomy radiotherapy stratified by skin involvement status	5
Development and results of a patient-reported treatment experience questionnaire on a 1.5 T MR-Linac	5
Primary site stereotactic ablative body radiotherapy in localized, recurrent, and metastatic renal cell carcinoma	5
Concurrent palliative radiation with pembrolizumab for platinum-refractory urothelial carcinoma is associated with improved overall survival	5
Prolonging deep inspiration breath-hold time to 3 min during radiotherapy, a simple solution	5
Defining radio-recurrent intra-prostatic target volumes using PSMA-targeted PET/CT and multi-parametric MRI	5
Clinical management of oligometastatic cancer: Applying multidisciplinary tumor board recommendations in practice	5
Deterioration of pancreatic exocrine function in carbon ion radiotherapy for pancreatic cancer	5
Salvage LATTICE radiotherapy for a growing tumour despite conventional radio chemotherapy treatment of lung cancer	5
Risk of stroke-specific mortality after radiotherapy in patients with primary brain tumours	5
Fractionated stereotactic radiotherapy of intracranial postoperative cavities after resection of brain metastases – Clinical outcome and prognostic factors	4
Outcomes and toxicities in oligometastatic patients treated with stereotactic body radiotherapy for adrenal gland metastases: A multi-institutional retrospective study	4
Stereotactic radiosurgery and combined immune checkpoint therapy with ipilimumab and nivolumab in patients with melanoma brain metastases: A retrospective monocentric toxicity analysis	4
Reproducibility of Deep-Inspiration Breath Hold treatments on Halcyon™ performed using the first clinical version of AlignRT InBore™: Results of CYBORE study	4
Mepitel® film versus standard care for the prevention of skin toxicity in breast cancer patients treated with adjuvant radiotherapy: A randomized controlled trial	4

Multidisciplinary Treatment of Non-Spine Bone Metastases: Results of a Modified Delphi Consensus Process	4
Determining risk and predictors of head and neck cancer treatment-related lymphedema: A clinicopathologic and dosimetric data mining approach using interpretable machine learning and ensemble feature	4
Predicting the benefit of stereotactic body radiotherapy of colorectal cancer metastases	4
Bridging the care gap: patients’ needs and experiences regarding shared decision-making in radiotherapy	4
MucoUp® as a spacer in brachytherapy for uterine cervical cancer: A first-in-human experience	4
C. elegans: A potent model for high-throughput screening experiments investigating the FLASH effect	4
Optimal and actual rates of Stereotactic Ablative Body Radiotherapy (SABR) utilisation for primary lung cancer in Australia	4
Artificial intelligence guided physician directive improves head and neck planning quality and practice Uniformity: A prospective study	4
Phase I trial of the MEK inhibitor selumetinib in combination with thoracic radiotherapy in non-small cell lung cancer	4
Letter to the Editor	4
The carbon footprint of external beam radiotherapy and its impact in health technology assessment	4
A prospective study assessing the pattern of response of local disease at DCE-MRI after salvage radiotherapy for prostate cancer	4
Impact of pretreatment second look 18FDG-PET/CT on stage and treatment changes in head and neck cancer	4
GI factors, potential to predict prostate motion during radiotherapy; a scoping review	4
The need for consensus on delineation and dose constraints of dentofacial structures in paediatric radiotherapy: Outcomes of a SIOP Europe survey	4
Time- and dose-dependent volume decreases in subcortical grey matter structures of glioma patients after radio(chemo)therapy	4
Outcomes and predictive factors after second stereotactic radiosurgery for refractory trigeminal neuralgia	4
Access to brachytherapy treatment for cervical cancer management in Africa	4
Postoperative radiotherapy alone is as effective as postoperative chemoradiotherapy in patients with pT4aN0 gingival cancer with negative surgical margins	4
Supraventricular cardiac conduction system exposure in breast cancer patients treated with radiotherapy and association with heart and cardiac chambers doses	4
Cervical body composition on radiotherapy planning computed tomography scans predicts overall survival in glioblastoma patients	4
Inter-clinician delineation variation for a new highly-conformal flank target volume in children with renal tumors: A SIOP-Renal Tumor Study Group international multicenter exercise	4
Prospective evaluation of intensity-modulated radiotherapy toxicity in extremity soft tissue sarcomas patients: A role for irradiated healthy soft tissue volume?	4
Interrater agreement of contouring of the neurovascular bundles and internal pudendal arteries in neurovascular-sparing magnetic resonance-guided radiotherapy for localized prostate cancer	4
Urethra-sparing prostate cancer radiotherapy: Current practices and future insights from an international survey	4
Prognosis of severe lymphopenia after postoperative radiotherapy in non-small cell lung cancer: Results of a long-term follow up study	4
Helical tomotherapy for post-mastectomy radiation therapy with or without breast implant: a single institution experience	4
Postoperative complications after esophagectomy for cancer, neoadjuvant chemoradiotherapy compared to neoadjuvant chemotherapy: A single institutional cohort study	4
Enhancing radiotherapy outcomes in rectal cancer: A systematic review of targeting hypoxia-induced radioresistance	4
Acute and late toxicity patterns of moderate hypo-fractionated radiotherapy for prostate cancer: A systematic review and meta-analysis	4
Irradiation of localized prostate cancer in the elderly: A systematic literature review	4
Exploring causes and consequences of early discontinuation of durvalumab after chemoradiotherapy for non-small cell lung cancer	3
Late Adverse Health Outcomes and Quality of Life after curative radiotherapy + long-term ADT in Prostate Cancer Survivors: Comparison with men from the general population	3
An exploratory analysis of MR-guided fractionated stereotactic radiotherapy in patients with brain metastases	3
Radiotherapy-induced Hypothalamic-Pituitary axis dysfunction in adult Brain, head and neck and skull base tumor patients – A systematic review and Meta-Analysis	3
Cosmetic outcome in patients with early stage breast cancer after accelerated partial breast irradiation using intraoperative or external beam radiotherapy	3
Adaptive radiotherapy for breast cancer	3
Prospective radiotherapy quality Assurance leads to delineation guideline refinements for recurrent rectal cancer: Experience from the PelvEx II study	3
Comparing pre-operative versus post-operative single and multi-fraction stereotactic radiotherapy for patients with resectable brain metastases	3
#radonc: Growth of the global radiation oncology Twitter network	3
Pelvic insufficiency fractures after intensity modulated radiation therapy combined with chemotherapy for cervix carcinoma: Incidence and impact of bone mineral density	3
Assessing concordance between patient-reported and investigator-reported CTCAE after proton beam therapy for prostate cancer	3
Elective pelvic nodal irradiation in the setting of ultrahypofractionated versus moderately hypofractionated and conventionally fractionated radiotherapy for prostate cancer: Outcomes from 3 prospecti	3
The oxygen puzzle in FLASH radiotherapy: A comprehensive review and experimental outlook	3
External validation of pulmonary radiotherapy toxicity models for ultracentral lung tumors	3
Dynamic tumor-tracking stereotactic body radiotherapy with real-time monitoring of liver tumors using a gimbal-mounted linac: A multi-institutional phase II study	3
Personalized neck irradiation guided by sentinel lymph node biopsy in patients with squamous cell carcinoma of the oropharynx, larynx or hypopharynx with a clinically negative neck: (Chemo)radiotherap	3
Real-world utilisation of brachytherapy boost and patient-reported functional outcomes in men who had external beam radiation therapy for prostate cancer in Australia	3
The value of plasma hypoxia markers for predicting imaging-based hypoxia in patients with head-and-neck cancers undergoing definitive chemoradiation	3
SABR for oligometastatic renal cell carcinoma	3
Health care system factors associated with receipt of treatment and treatment intent in stage III non-small cell lung cancer: A population-based study in Ontario	3
Factors associated with complex oral treatment device usage in patients with head and neck cancer	3
Clinical outcomes and risk factors for local failure and visual impairment in patients treated with Ru-106 brachytherapy for uveal melanoma	3
MAPK11 (p38β) is a major determinant of cellular radiosensitivity by controlling ionizing radiation-associated senescence: An in vitro study	3
A multi-centre survey reveals variations in the standard treatments and treatment modifications for head and neck cancer patients during Covid-19 pandemic	3
The technical design and concept of a PET/CT linac for biology-guided radiotherapy	3
Adjuvant PD-1 antibody in recurrent, previously irradiated oral cavity cancer treated with salvage surgery	3
Incidental dose distribution to contralateral internal mammary nodes in breast cancer patients undergoing adjuvant radiotherapy	3
Design and evaluation of a deep learning-based automatic segmentation of maxillary and mandibular substructures using a 3D U-Net	3
Thyroid volume changes following adjuvant radiation therapy for breast cancer	3
Institutional experience of using active breathing control for paediatric and teenage patients receiving thoraco-abdominal radiotherapy	3
Salvage radiotherapy for relapsed/refractory non‐Hodgkin lymphoma following CD19 chimeric antigen receptor T-cell (CART) therapy	3
Impact of endorectal filling on interobserver variability of MRI based rectal primary tumor delineation	3
Lung cancer epidermal growth factor receptor mutations and radiotherapy response: A multicentre clinical study	3
Ultra-hypofractionated one-week locoregional radiotherapy for patients with early breast cancer: Acute toxicity results	3
Cleaning radiotherapy contours for radiomics studies, is it worth it? A head and neck cancer study	3
Impact and optimal timing of local therapy addition in borderline resectable or locally advanced pancreatic cancer after FOLFIRINOX chemotherapy	3
Re-irradiation with concurrent and maintenance nivolumab in locally recurrent and inoperable squamous cell carcinoma of the head and neck: A single-center cohort study	3
Comment on Hunt et al., “Feasibility of magnetic resonance guided radiotherapy for the treatment of bladder cancer”	3
Long-term outcomes of an esophagus-preserving chemoradiotherapy strategy for patients with endoscopically unresectable stage I thoracic esophageal squamous cell carcinoma	3
Postoperative SBRT in the treatment of early-stage oropharyngeal and oral cavity cancers with high-risk margins: A dosimetric comparison of volumetric modulated arc therapy with or without non-coplana	3
Biopsy-derived oral keratinocytes – A model to potentially test for oral mucosa radiation sensitivity	3
Reply to: Comment on “Repeated HyperArc radiosurgery for recurrent intracranial metastases and dosimetric analysis of recurrence pattern to account for diffuse dose effect on microscopical disease”	3
Online adaptive radiotherapy for head and neck cancers on the MR linear Accelerator: Introducing a novel modified Adapt-to-Shape approach	3
Feasibility and safety of single-fraction sub-ablative radiotherapy with systemic therapy in colorectal cancer patients with ≤ 10 metastases: A multicenter pilot study (NCT05375708)	2
Detection of alteration in carotid artery volumetry using standard-of-care computed tomography surveillance scans following unilateral radiation therapy for early-stage tonsillar squamous cell carcino	2
Early complete tumor response as a survival predictor in hepatocellular carcinoma patients receiving stereotactic body radiation therapy	2
Organ-sparing techniques and dose-volume constrains used in breast cancer radiation therapy – Results from European and Latin American surveys	2
Salvage low-dose-rate brachytherapy for locally recurrent prostate cancer after definitive irradiation	2
Stereotactic body radiotherapy to defer systemic therapy in patients with oligorecurrent disease	2

Prognostic impact of biologically equivalent dose in stereotactic body radiotherapy for renal cancer	2
18F-DCFPyL (PSMA) PET as a radiotherapy response assessment tool in metastatic prostate cancer	2
Fully automatic reconstruction of prostate high-dose-rate brachytherapy interstitial needles using two-phase deep learning-based segmentation and object tracking algorithms	2
Effects of proton therapy on regional [18F]FDG uptake in non-tumor brain regions of patients treated for head and neck cancer	2
Enhanced head and neck radiotherapy target definition through multidisciplinary delineation and peer review: A prospective single-center study	2
Empirical planning target volume modeling for high precision MRI guided intracranial radiotherapy	2
Cochlear-optimized treatment planning in photon and proton radiosurgery for vestibular schwannoma patients	2
In response to Korreman s. et al. Radiation oncologists are, above all, medical doctors	2
European radiation oncology after one year of COVID-19 pandemic	2
Large language models for pretreatment education in pediatric radiation oncology: A comparative evaluation study	2
Prospective planning comparison of magnetic resonance-guided vs. internal target volume-based stereotactic body radiotherapy of hepatic metastases – Which patients do really benefit from an MR-linac?	2
Comparison of four-year toxicities and local control of ultra-hypofractionated vs moderate-hypofractionated image guided prostate radiation with HDR brachytherapy boost: A phase I-II single institutio	2
Multi-institutional experience of MR-guided stereotactic body radiation therapy for adrenal gland metastases	2
PD-1 and PD-L1 expression predict regression and prognosis following neoadjuvant radiochemotherapy of oesophageal adenocarcinoma	2
In response to Chuong et al.	2
Outcomes of Isocitrate Dehydrogenase Wild Type Glioblastoma after Re-irradiation	2
Exposure of the heart and cardiac valves in women irradiated for breast cancer 1970–2009	2
Pseudo-siamese network combined with dosimetric and clinical factors, radiomics features, CT images and 3D dose distribution for the prediction of radiation pneumonitis: A feasibility study	2
Acute enteritis with pelvic SBRT: Influence of bowel delineation methods	2
Circulating cell-free DNA as predictor of pathological complete response in locally advanced rectal cancer patients undergoing preoperative chemoradiotherapy	2
Clinical relevance of the radiation dose bath in lower grade glioma, a cross-sectional pilot study on neurocognitive and radiological outcome	2
The value of intervention with radiotherapy after first-line chemo-immunotherapy in locally advanced or metastatic esophageal squamous cell carcinoma: A multi-center retrospective study	2
ESTRO ACROP guideline on prostate bed delineation for postoperative radiotherapy in prostate cancer	2
A year of pandemic for European particle radiotherapy: A survey on behalf of EPTN working group	2
Prospective assessment of stress and health concerns of radiation oncology staff during the COVID-19 pandemic	2
Targeting K-Ras-mediated DNA damage response in radiation oncology: Current status, challenges and future perspectives	2
Clinical outcomes of MR-guided adrenal stereotactic ablative radiotherapy with preferential sparing of organs at risk	2
Single fraction of HDR brachytherapy for prostate cancer: Results of the SiFEPI phase II prospective trial	2
Analysis of data to Advance Personalised Therapy with MR-Linac (ADAPT-MRL)	2
Treatment-related toxicity, utility and patient-reported outcomes of head and neck cancer patients treated with proton therapy: A longitudinal study	2
18FDG positron emission tomography mining for metabolic imaging biomarkers of radiation-induced xerostomia in patients with oropharyngeal cancer	2
Is bilateral radiotherapy necessary for patients with unilateral squamous cell carcinoma of unknown primary of the head and neck region?	2
Mid-treatment adaptive planning during thoracic radiation using 68 Ventilation-Perfusion Positron emission tomography	2
PROMIS scores of patients undergoing neoadjuvant and adjuvant radiation therapy for surgically excised soft tissue sarcoma	2
Patterns of locoregional recurrences and suggestion of the clinical target volume in resected perihilar extrahepatic cholangiocarcinoma	2
A knowledge graph representation of baseline characteristics for the Dutch proton therapy research registry	2
Helical tomotherapy craniospinal irradiation in primary brain tumours: Toxicities and outcomes in a peadiatric and adult population	2
All for one: Collaboration between dermatologist, radiation oncologist and radiologist in the clinical management of “difficult to treat” non melanoma skin cancer	2
Quality-of-life and toxicity in cancer patients treated with multiple courses of radiation therapy	2
Nonoperative versus operative approach according to the response to neoadjuvant chemoradiotherapy for rectal cancer: A prospective cohort study	2
Impact of tumor position displacement during end-exhalation breath-hold condition on tumor dose in lung stereotactic body radiation therapy using volumetric modulated arc therapy	2
The effect of low-dose radiation spillage during stereotactic radiosurgery for brain metastases on the development of de novo metastases	2
Same-Day Magnetic Resonance-Guided Single-Fraction stereotactic body radiation therapy for painful Non-Spine bone metastases – A Single-Center study (“BONE SHOT”)	2
Patient reported toxicity and quality of life after hypofractionated high-dose intensity-modulated radiotherapy for intermediate- and high risk prostate cancer	2
Death without progression as an endpoint to describe cardiac radiation effects in locally advanced non-small cell lung cancer	2
Enhanced radiosensitivity of head and neck cancer cells to proton therapy via hyperthermia-induced homologous recombination deficiency	2
Application and progress of artificial intelligence in radiation therapy dose prediction	2
10-Year oncological outcome report after second conservative treatment for ipsilateral breast tumor event	2
Young oncologists benefit more than experts from deep learning-based organs-at-risk contouring modeling in nasopharyngeal carcinoma radiotherapy: A multi-institution clinical study exploring working e	2
Construction and validation of a prognostic nine-gene signature associated with radiosensitivity in head and neck squamous cell carcinoma	2
Stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancer – Acute toxicity and patient-reported outcomes in the prospective, multicenter SMILE phase II trial	2
New curative approach using embolization followed by moderate-dose radiotherapy after surgical failure for large right heart metastasis	2
Pelvic lymph node motion during cone-beam computed tomography guided stereotactic radiotherapy	2
Proton beam therapy for extrahepatic biliary tract cancer: Analysis with prospective multi-institutional patients’ registration database, Proton-Net	2
Radiation therapy for primary orbital and ocular adnexal lymphoma	2
High-dose-rate brachytherapy boost for elderly patients with intermediate to high-risk prostate cancer: 5-year clinical outcome of the PROSTAGE cohort	2
How to contour the different heart subregions for future deep-learning modeling of the heart: A practical pictorial proposal for radiation oncologists	2
From pre-clinical studies to human treatment with proton-minibeam radiation therapy: adapted Idea, Development, Exploration, Assessment and Long-term evaluation (IDEAL) framework for innovation in rad	2
Spatially fractionated radiotherapy (Lattice SFRT) in the palliative treatment of locally advanced bulky unresectable head and neck cancer	2
Who should receive single-fraction palliative radiotherapy for gastric cancer bleeding?: An exploratory analysis of a multicenter prospective observational study (JROSG 17-3)	2
Reduced-dose WBRT combined with SRS for 1–4 brain metastases aiming at minimizing neurocognitive function deterioration without compromising brain tumor control	2
Splenic irradiation contributes to grade ≥ 3 lymphopenia after adjuvant chemoradiation for stomach cancer	2
Half body irradiation (HBI) for bone metastases in the modern radiotherapy technique era – A systematic review	1
Predictive clinical and dosimetric parameters for risk of relapse in early-stage non-small cell lung cancer treated by SBRT: A large single institution experience	1
A study on predicting cases that would benefit from proton beam therapy in primary liver tumors of less than or equal to 5 cm based on the estimated incidence of hepatic toxicity	1
Pre-treatment visualization of predicted radiation-induced acute alopecia in brain tumour patients	1
Elective pelvic nodal irradiation for elderly patients with high-risk prostate cancer: A more patient-oriented approach	1
Re-irradiation for recurrent cervical cancer: A single institutional experience	1
Remineralization of lytic spinal metastases after radiation therapy – A retrospective cohort study comparing conventional external beam radiation therapy with stereotactic ablative body radiation	1
Associations of dose to the urethra and long-term patient-reported outcomes after radiotherapy with EBRT and HDR brachytherapy boost for prostate cancer	1
Long-term outcomes of intraoperatively-placed applicator brachytherapy for rapid completion of breast conserving treatment: An analysis of a prospective registry data	1
Stereotactic radiosurgery results for brain metastasis patients with renal cancer: A validity study of Renal Graded Prognostic Assessment and proposal of a new grading index (JLGK2101 Study)	1
How to protect the proximal bronchial tree during stereotactic radiotherapy of ultracentral lung tumors: Lessons from MR-guided treatment	1
Elective pelvic nodal irradiation in elderly men treated with hypofractionated radiotherapy	1
Implementation of ultra-hypofractionated radiotherapy schedules for breast cancer during the COVID-19 pandemic in the Netherlands	1
Prostate cancer radiotherapy and incidental testicular irradiation: Impact on gonadal function	1
A pilot study to evaluate the combination of surgery and brachytherapy for local tumor control in young children with perianal rhabdomyosarcoma	1
Stereotactic body radiation therapy for prostate cancer after surgical treatment of prostatic obstruction: Impact on urinary morbidity and mitigation strategies	1
AI-assisted clinical decision making (CDM) for dose prescription in radiosurgery of brain metastases using three-path three-dimensional CNN	1
Definitive particle therapy using protons or carbon ions for dedifferentiated liposarcoma	1
Repeated HyperArc radiosurgery for recurrent intracranial metastases and dosimetric analysis of recurrence pattern to account for diffuse dose effect on microscopical disease	1
Machine learning for normal tissue complication probability prediction: Predictive power with versatility and easy implementation	1
A scoping review of small animal image-guided radiotherapy research: Advances, impact and future opportunities in translational radiobiology	1
Predictive and prognostic value of inflammatory markers in locally advanced rectal cancer (PILLAR) – A multicentric analysis by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Gas	1
A dosimetric comparison of different radiotherapy modalities for Non-Resected oligometastatic liver Disease	1
Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study protocol	1
Clinical implementation of standardized neurocognitive assessment before and after radiation to the brain	1
Impact of hyperfractionated re-irradiation on quality of life in patients with recurrent or second primary head and neck cancer, a prospective single institutional study	1
Patterns of metastatic spread and tumor burden in unselected cancer patients using PET imaging: Implications for the oligometastatic spectrum theory	1
DNA-methylation and genomic copy number in primary tumors and corresponding lymph node metastases in prostate cancer from patients with low and high Gleason score	1
MRI guided online adaptive radiotherapy and the dosimetric impact of inter- and intrafractional motion in patients with cervical cancer	1
Artificial intelligence in interventional radiotherapy (brachytherapy): Enhancing patient-centered care and addressing patients’ needs	1
The dogma of Cetuximab and Radiotherapy in head and neck cancer – A dawn to dusk journey	1
Circulating neutrophils and tumor-associated myeloid cells function as a powerful biomarker for response to chemoradiation in locally advanced cervical cancer	1
Excessive waitlists and delays to treatment with low-dose-rate brachytherapy predict an increased risk of recurrence and metastases in intermediate-risk prostatic carcinoma	1